Roche (Switzerland)

935.0k citations
21.2k papers ·

Impact in

  • Immunology top 1%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Neuroscience and Neuropharmacology Research
    • Neurotransmitter Receptor Influence on Behavior

Papers in

Roche (Switzerland)

19.0k papers receiving 852.0k citations

Peers

Roche (Switzerland)
Comparison fields: 5 of 249
  • Immunology 100.3k
  • Cellular and Molecular Neuroscience 83.4k
  • Oncology 112.5k
  • Molecular Biology 298.0k
  • Biological Psychiatry 8.8k
Replace Novartis (Switzerland) with:
Novartis (Switzerland) Switzerland
German Cancer Research Center Germany
Max Planck Institute of Biochemistry Germany
Institut Pasteur France
Helmholtz Zentrum München Germany
DKFZ-ZMBH Alliance Germany
European Molecular Biology Laboratory Germany
The Netherlands Cancer Institute Netherlands
Janssen (Belgium) Belgium
Hammersmith Hospital United Kingdom
Roche (Switzerland) relative to Novartis (Switzerland) Switzerland Novartis (Switzerland)'s profile →
Citations per field
00.5×1.5×
Novartis (Switzerland) · 1×
Citations per year

Countries citing scholars working at Roche (Switzerland)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Roche (Switzerland). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Roche (Switzerland) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roche (Switzerland) more than expected).

Fields of papers published by authors at Roche (Switzerland)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Roche (Switzerland) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Roche (Switzerland) at the time of their publication.

About Roche (Switzerland)

In recent decades, authors affiliated with Roche (Switzerland) have published 21.2k papers, which have received a total of 935.0k indexed citations . Scholars at this organization have produced 2.7k papers in Oncology, 1.9k papers in Immunology, 6.2k papers in Molecular Biology, 1.4k papers in Cellular and Molecular Neuroscience and 736 papers in Genetics on the topics of Monoclonal and Polyclonal Antibodies Research (1.1k papers), Neuroscience and Neuropharmacology Research (708 papers), Receptor Mechanisms and Signaling (629 papers), Chemical Synthesis and Analysis (493 papers), Computational Drug Discovery Methods (470 papers), Lymphoma Diagnosis and Treatment (460 papers), Pharmacogenetics and Drug Metabolism (434 papers) and T-cell and B-cell Immunology (433 papers). Their work is cited by papers focused on Immunology (100.3k citations), Cellular and Molecular Neuroscience (83.4k citations), Oncology (112.5k citations), Molecular Biology (298.0k citations) and Biological Psychiatry (8.8k citations). Authors at Roche (Switzerland) collaborate with scholars in Switzerland, United States and Germany and have published in prestigious journals including Helvetica Chimica Acta, Journal of Clinical Oncology, Blood, Annals of Oncology and Journal of Biological Chemistry. Some of Roche (Switzerland)'s most productive authors include W. Helfrich, Klaus Müller, A. Pletscher, François Diederich, Ueli Gubler, Steven V. Ley, W. Haefely, Horst Bluethmann, Beth J. Hoffman and Hans R. Baumgartner.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact